• Press Center

TusHoldings Becomes a Shareholder of Cambridge Innovation Capital to Promote Chinese-British Sci-tech CooperationPrint

Post Time:2019-04-06来源:Tusholdings

Powered by University of Cambridge, Cambridge Innovation Capital Plc (CIC), an investment platform focusing on investing in the sci-tech industry in the Cambridge ecosystem, has recently completed a new round of financing. Tus-S&T Service Group has become one of CIC’s new shareholders.

With University of Cambridge as its major shareholder, Cambridge Innovation Capital is the preferred partner for University of Cambridge’s investment in technological projects and enjoys priority access to the scientific and technological achievements of University of Cambridge. Cambridge Innovation Capital has successfully invested in a number of well-known hi-tech companies in Cambridge Region, including Bicycle Therapeutics, CMR Surgical and Jukedeck.

With more than 3,000 high-tech companies, Cambridge Region is one of the fastest growing economies in the UK and an important cluster-based research and innovation centre around the world, leading the way in terms of R&D and innovation capabilities in biopharmaceuticals, healthcare, computers & big data, artificial intelligence, energy and environment. The funds raised through this financing will be used to support Cambridge Innovation Capital’s investment in new opportunities emerging in the sci-tech ecosystem of Cambridge Region.

Cambridge Innovation Capital’s emphasis on clustering innovation and global innovation networks is the main reason for its cooperation with TusHoldings. As a leader in Cambridge’s cluster-based research and innovation, Cambridge Innovation Capital focuses on the transformation of scientific and technological achievements in the sci-tech industry, especially in the field of biomedicine, and is adept at effectively deploying innovative technologies, hi-tech personnel and experienced entrepreneurs for market-oriented operation.

Through this cooperation, TusHoldings’ extensive global innovation network will not only conduce to improving the company investment business of Cambridge Innovation Capital, but also help TusHoldings to go deep into Cambridge’s sci-tech innovation cluster, establish a network of leading-edge scientific and technological achievements in the UK, and effectively integrate such leading-edge technologies as biomedicine and artificial intelligence with the Chinese market.

After its investment in the establishment of TusPark Newcastle and TusPark Cambridge and in a number of technological projects, becoming a shareholder of the CIC investment platform also marks TusHolding’ steady and in-depth progress of its “park-industry-fund” triple helix model in the UK.

Extended reading:

About TusPark Cambridge: TusHoldings has set up TusPark Cambridge in cooperation with Trinity College, Cambridge and Cambridge Science Park in Cambridge Region. Bio-Innovation Centre, invested in and operated by TusHoldings in TusPark Cambridge and representing the highest level of hardware and software in Cambridge Region, will be put into use in the second quarter of this year. Bio-Innovation Centre is a key project of cooperation between TusHoldings and Trinity College, Cambridge, and the first life science and technology innovation base invested in by TusHoldings in the history of Cambridge Science Park.

Cambridge Region is the world’s leading life science and technology innovation valley, where star companies from Nobel Prize winners to biomedicine have emerged continuously over the years. The establishment of Bio-Innovation Centre will further integrate innovative and high-quality resources in the biomedical industry in Cambridge Region and throughout the UK. At the same time, with the help of TusHoldings’ global innovation network, it will accelerate the commercialization, industrialization and scale of the world’s leading technologies in Cambridge Region, and first introduce Cambridge’s advantageous technologies into the Chinese market.

About Cambridge Innovation Capital: The recent achievements of some companies with investment from Cambridge Innovation Capital include:

1.   Inivata has made certain treatment decisions related to advanced non-small cell lung cancer in the US InVision First-Lung test;

2.   PragmatIC, the world’s leading manufacturer of ultra-low-cost flexible electronic products, launched the first products of the ConnectIC series;

3.   Imagen, the award-winning service video management platform company, has completed its Series B financing to expand its global business, especially in the US and European markets;

4.   GeoSpock, the spatial big data integration company, launched a breakthrough spatial big data platform.

More information on Cambridge Innovation Capital can be found at: